Stay updated with breaking news from Council On Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Biopharmaceutical company Incyte plans to expand its headquarters operations in Wilmington, Delaware. The project is expected to create up to 500 jobs over the coming years.
Delaware biopharmaceutical company Incyte purchased two buildings in downtown Wilmington, DE, which is set to bring in 500 new jobs.
Delaware based Incyte Corporation has announced it has acquired two buildings in downtown Wilmington with plans to initially relocate 300 jobs from Pennsylvania to the city.
Incyte will buy two former MBNA buildings in downtown Wilmington, Bracebridge I and Bracebridge III, which will allow the biopharmaceutical company to move
Veteran-owned Phase Sensitive Innovations will expand R&D and manufacturing facilities to meet defense contracts.